Literature DB >> 8142952

Tissue specific expression of an alpha-skeletal actin-lacZ fusion gene during development in transgenic mice.

E A Asante1, J M Boswell, D W Burt, G Bulfield.   

Abstract

Transgenic mice carrying a chimaeric transgene containing 730 bp of the 5'-flanking sequences and the entire first intron of the rat alpha-skeletal actin gene fused to the lacZ reporter gene have been produced by microinjection. The lacZ reporter gene was used to verify the suitability of using the rat alpha-actin promoter elements to target expression of genes of agricultural and therapeutic value exclusively to skeletal and heart muscle cells and fibres of transgenic mice. Expression of the transgene indicates a tightly regulated developmental and muscle specific control of the rat alpha-skeletal actin gene, making it a useful promoter for gene targeting to muscle tissues. The cells destined to form muscle tissues in these transgenic mice are readily visualized in intact embryos by staining for beta-galactosidase activity, making them a suitable animal model for studying the origin and development of skeletal and cardiac muscle tissues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8142952     DOI: 10.1007/bf01976028

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  23 in total

Review 1.  Progress toward human gene therapy.

Authors:  T Friedmann
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

2.  Histochemical staining of clonal mammalian cell lines expressing E. coli beta galactosidase indicates heterogeneous expression of the bacterial gene.

Authors:  G R MacGregor; A E Mogg; J F Burke; C T Caskey
Journal:  Somat Cell Mol Genet       Date:  1987-05

3.  Metameric pattern development in the embryonic axis of the mouse. I. Differentiation of the cranial segments.

Authors:  S Meier; P P Tam
Journal:  Differentiation       Date:  1982       Impact factor: 3.880

4.  Alpha-skeletal actin messenger RNA increases in acute right ventricular hypertrophy.

Authors:  P R Bakerman; K R Stenmark; J H Fisher
Journal:  Am J Physiol       Date:  1990-04

5.  Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs.

Authors:  G Acsadi; G Dickson; D R Love; A Jani; F S Walsh; A Gurusinghe; J A Wolff; K E Davies
Journal:  Nature       Date:  1991-08-29       Impact factor: 49.962

6.  Introns increase transcriptional efficiency in transgenic mice.

Authors:  R L Brinster; J M Allen; R R Behringer; R E Gelinas; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

7.  Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice.

Authors:  D J Wells; K E Wells; F S Walsh; K E Davies; G Goldspink; D R Love; P Chan-Thomas; M G Dunckley; T Piper; G Dickson
Journal:  Hum Mol Genet       Date:  1992-04       Impact factor: 6.150

Review 8.  Somitomeres: mesodermal segments of vertebrate embryos.

Authors:  A G Jacobson
Journal:  Development       Date:  1988       Impact factor: 6.868

9.  Transcripts of alpha-cardiac and alpha-skeletal actins are early markers for myogenesis in the mouse embryo.

Authors:  D A Sassoon; I Garner; M Buckingham
Journal:  Development       Date:  1988-09       Impact factor: 6.868

10.  The formation of mesodermal tissues in the mouse embryo during gastrulation and early organogenesis.

Authors:  P P Tam; R S Beddington
Journal:  Development       Date:  1987-01       Impact factor: 6.868

View more
  2 in total

1.  Developmental expression of the alpha-skeletal actin gene.

Authors:  Laura D Bertola; Elisabeth B Ott; Sander Griepsma; Freek J Vonk; Christoph P Bagowski
Journal:  BMC Evol Biol       Date:  2008-06-02       Impact factor: 3.260

2.  Changes in Skeletal Muscle and Body Weight on Sleeping Beauty Transposon-Mediated Transgenic Mice Overexpressing Pig mIGF-1.

Authors:  Bo Gao; Wei Wang; Han Wu; Cai Chen; Dan Shen; Saisai Wang; Wei Chen; Li Zhang; Shuheng Chan; Chengyi Song
Journal:  Biochem Genet       Date:  2018-02-22       Impact factor: 1.890

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.